1.Presence of circulating autoantibodies against bronchial epithelia cell in patients with nonatopic asthma.
Dong Ho NAHM ; Hyunee YIM ; Hyun Joo LEE ; Eui Jin YIM ; Eun Ah CHOI ; Sun Sin KIM ; Soo Keol LEE ; Hae Sim PARK
Journal of Korean Medical Science 2000;15(6):631-634
Allergic response to common environmental agents has been regarded as a main pathogenetic mechanism of bronchial asthma. However, allergic sensitization (atopy) can not be detected in a siginificant number of adult asthmatic patients. The etiology of nonatopic asthma has not yet been defined. To evaluate the possible involvement of autoimmune response against bronchial mucosa in the pathogenesis of nonatopic asthma, we performed indirect immunofluorescence staining of fresh frozen human bronchial mucosa tissue using serum samples from patients with atopic and nonatopic asthma, healthy controls, and patients with systemic lupus erythematosus. On immunostaining, circulating IgG autoantibodies against bronchial mucosa were detected in 2 (9.1%) of 22 patients with nonatopic asthma and in none of 22 patients with atopic asthma and of 22 healthy controls. IgG autoantibodies from the two patients with nonatopic asthma predominantly stained the cytoplasmic membrane of basal cells in bronchial epithelium. Serum samples from 10 patients with systemic lupus erythematosus immunostained the nucleus of epithelial cells in whole layer of bronchial epithelium. This study showed the presence of circulating IgG autoantibodies against the bronchial epithelial cell in a small portion of patients with nonatopic asthma. Further studies may be necessary to evaluate the possible involvement of autoimmune mechanism in the pathogenesis of nonatopic asthma.
Asthma/immunology*
;
Autoantibodies/immunology*
;
Autoantibodies/blood
;
Bronchi/immunology*
;
Epithelial Cells/immunology
;
Human
;
Immunity, Mucosal/immunology
;
Respiratory Mucosa/immunology*
2.Minimizing the antigenicity of tracheal allografts by using a technique of cryopreservation.
Lian-Zhao WANG ; Gang ZHOU ; Fei FAN ; Feng ZHANG ; Fu-Shan XUE ; Jie LUAN ; Guo-Bin CAI ; Fan-Hui MENG ; Pei-Tao WANG ; Hua-Bing WANG
Chinese Journal of Plastic Surgery 2004;20(4):297-300
OBJECTIVETo investigate the proper time of cryo-preserving tracheal allograft so as to minimize its antigenicity.
METHODSOn a dog model, this study was carried out by allografting a tracheal into a muscular flap formed with sternocephalic muscle and sternohyoid--sternothyroid muscle. The tracheal was treated with cryopreservation in defferent intervals. The viability of the graft was evaluated by the examination of fiberoptic bronchoscopy, histopathology and microangiography. The blood flow of the tracheal mucous was measured with a blood flowmeter and the survival area was decided in the calculation of the percentage.
RESULTSThere are no significant differences in the mucous membrane appearance and the mucosal blood flow one week after the surgery among the non-cryopreservation group and the groups treated with cryopreservation in 1 day, 2 weeks, 4 weeks, 6 weeks and 8 weeks. The graft was found to start necrosis 2 weeks after the transplantation with the infiltration of mononuclear cells examined under light microscope in almost all of the groups, especially in the non-cryopreservation group and the groups treated with cryopreservation in 1 day, 2 weeks. However, there was no significant difference among the autograft group and the allograft groups cryopreservated in 6 weeks and 8 weeks, and the infiltration of the mononuclear cells was not found in these groups either.
CONCLUSIONThe antigenicity of the tracheal allografts could be significantly decreased by the treatment of cryopreservation over 6 weeks.
Animals ; Bronchoscopes ; Cryopreservation ; methods ; Dogs ; Flowmeters ; Models, Animal ; Respiratory Mucosa ; blood supply ; pathology ; Trachea ; immunology ; pathology ; transplantation ; Transplantation, Homologous
3.Effect of growth inhibition of the secretory protein SPLUNC1 on Pseudomonas aeruginosa.
Hou-de ZHOU ; Ming-hua WU ; Lei SHI ; Ming ZHOU ; Yi-xin YANG ; Jin ZHAO ; Tan DENG ; Xiao-ling LI ; Shou-rong SHENG ; Gui-yuan LI
Journal of Central South University(Medical Sciences) 2006;31(4):464-469
OBJECTIVE:
To express the recombinant SPLUNC1 protein in HNE1 cells and to study its function of bactericidal and binding to lipopolysaccharide (LPS).
METHODS:
Full length of SPLUNC1 gene was cloned into pCMV-tag4A vector and stably transfected into HNE1 cell lines, the supernatant of cell cultures was collected. After being treated with the supernatant, the Pseudomonas aeruginosa was seeded to LB soft agar plate, and the bacteria clones were counted and analyzed. For in vitro LPS binding assay, LPS was coated to 96-well plates. We incubated in the plate with SPLUNC1 protein, and detected the binded SPLUNC1 protein by ELISA. Incubating the FITC-LPS with the SPLUNC1 stably transfected or control cells, the intracellular intensity of fluorescence was observed under the fluorescence microscope.
RESULTS:
SPLUNC1 inhibited the bacteria clone formation obviously. Although the binding efficiency of LPS and SPLUNC1 in vitro was very low, more FITC-LPS entered into the SPLUNC1 stably transfected cells.
CONCLUSION
SPLUNC1 can inhibit the growth of Pseudomonas aeruginosa and bind LPS, and play an important defensive role in innate immunity of the upper airway.
Cell Line, Tumor
;
Glycoproteins
;
isolation & purification
;
pharmacology
;
Humans
;
Membrane Proteins
;
chemistry
;
Nasopharyngeal Neoplasms
;
genetics
;
pathology
;
Phosphoproteins
;
isolation & purification
;
pharmacology
;
Pseudomonas aeruginosa
;
drug effects
;
Respiratory Mucosa
;
chemistry
;
immunology
;
Respiratory System
;
chemistry
;
immunology
;
Transfection